NCT03634592Completed
AF Ablation With the Ablation Index
A Prospective Registry of Atrial Fibrillation Ablation Using the Prediction of Lesion Depth Technology
Source: ClinicalTrials.gov · Last updated 5 Mar 2024
Brief summary (registry, in English)
This is an observational multicenter registry of atrial fibrillation catheter ablation performed using the ablation index technology.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 450 (actual)
- First submitted
- 2 Aug 2018
- Start date
- 1 Oct 2019
- Primary completion date
- 31 Dec 2022
- Lead sponsor
- Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health
- Diseases
- Atrial fibrillation
- NCT number
- NCT03634592
What you commit to
- Study type: Observational
- Participants enrolled: 450
- From 1 Oct 2019 to the primary completion date, 31 Dec 2022
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Presence of contraindications to AF ablation
Who the study is looking for
- indications for catheter ablation of atrial fibrillation;
- signed informed consent
Age in the registry: 19 years to 79 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Federal State Budgetary Institution "V. A. Almazov Federal North-West Medical Research Centre" of the Ministry of Health of the Russian Federation Coordinator of this site? Confirm its status | Saint Petersburg | Russia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.